APA (7th ed.) Citation

DeAngelo, D. J., Chen, Y., Cassaday, R. D., Hibma, J. E., Yang, D. Z., Garrett, M., . . . Kantarjian, H. M. (2026). Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia. Leukemia & Lymphoma, 1. https://doi.org/10.1080/10428194.2026.2714343

Chicago Style (17th ed.) Citation

DeAngelo, Daniel J., et al. "Dose Optimization of Single-agent Inotuzumab Ozogamicin in Adults with Relapsed/refractory Acute Lymphoblastic Leukemia." Leukemia & Lymphoma 2026: 1. https://doi.org/10.1080/10428194.2026.2714343.

MLA (9th ed.) Citation

DeAngelo, Daniel J., et al. "Dose Optimization of Single-agent Inotuzumab Ozogamicin in Adults with Relapsed/refractory Acute Lymphoblastic Leukemia." Leukemia & Lymphoma, 2026, p. 1, https://doi.org/10.1080/10428194.2026.2714343.